Agreement: Page 4

LifeMD, Cleared to partner with Allergenis

By LabPulse.com staff writers

The partnership will combine Cleared's telehealth structure with Allergenis' peanut allergy diagnostic blood test, and sets Cleared as Allergenis' exclusive telehealth provider.

August 21, 2022

FYR Dx, Medicover partner on assay, tech development

By LabPulse.com staff writers

The firms plan to support pharmaceutical companies with clinical trial assay development and implementation, codevelopment of novel diagnostic technologies, and companion diagnostic testing services.

August 16, 2022

Paige, Sonora Quest partner on digital pathology in Arizona

By LabPulse.com staff writers

The goal of the digital transformation project is to improve current diagnostic workflows and accelerate precision diagnoses for patients across Arizona, the firms said.

August 10, 2022

VolitionRx inks research deal with MD Anderson

By LabPulse.com staff writers

Financial and other terms of the agreement were not disclosed.

August 10, 2022

Nanopath secures $10M in Series A financing

By LabPulse.com staff writers

The financing was led by both Norwest Venture Partners and the Medtech Convergence Fund, with participation from Gingerbread Capital and Green D Ventures.

August 8, 2022

Metabolon, Mayo Clinic ink joint development agreement

By LabPulse.com staff writers

Metabolon will analyze patient clinical samples from multiple cohorts to identify disease biomarkers that Mayo Clinic would use to develop diagnostic tests.

August 8, 2022

BD, Labcorp to develop flow cytometry CDx

By LabPulse.com staff writers

Specifically, the agreement creates a framework for BD and Labcorp Drug Development to collaborate on flow cytometry-based CDx opportunities with pharmaceutical partners.

August 8, 2022

LucidDx Labs inks four provider deals

By LabPulse.com staff writers

Diagnostic laboratory network Alivio Health and PPOs Prime Healthcare, Three Rivers Provider Network, and Galaxy Health have all signed on with LucidDx Labs. As a result, persons covered by Alivio or the three PPOs will receive in-network access to Lucid's EsoGuard DNA test for early detection of esophageal precancer in at-risk chronic heartburn patients, according to the company.

August 1, 2022

PerkinElmer inks deal to divest businesses

By LabPulse.com staff writers

Of the purchase amount, $2.3 billion will be received at closing and $150 million will be payable contingent on the exit valuation New Mountain receives on a sale or other capital events related to the business. The new ownership is expected to retain the PerkinElmer name and brand for the applied, food, and enterprise services businesses.

July 31, 2022

Video from AACC: Beckman Coulter partners with Scopio

By Leo O'Connor

Dr. Peter Soltani, senior vice president and general manager at Beckman Coulter, and Itai Hayut, cofounder and CEO of Scopio Labs, spoke to LabPulse.com and ScienceBoard.net about the partnership.

July 31, 2022

Guardian Research, ThinkGenetic partner on rare diseases

By LabPulse.com staff writers

The collaboration utilizes the existing healthcare data science and clinical expertise of GRN and ThinkGenetic's experience in electronic health record (EHR) algorithm development. Together, the collaboration will promote accurate diagnosis and healthcare provider support integrating rare genetic conditions into their practices.

July 27, 2022

Nanomix, Biotron ink distribution deal

By LabPulse.com staff writers

Under the terms of the deal, Biotron also will market the Nanomix S1 panel cartridge, which diagnoses infections, including sepsis, and future new product cartridges for the eLab system.

July 20, 2022

Previous Page

Page 4 of 16

Next Page